An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in Mice
Open Access
- 1 June 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 8, 645-656
Abstract
Introduction: Integrin α 6 is an attractive diagnostic biomarker for molecular imaging of hepatocellular carcinoma (HCC) as it has an extremely high positive rate (approximately 94%) in clinical early-stage HCC. In this study, based on our previously identified integrin α 6-targeted peptide, we developed an optimized integrin α 6-targeted magnetic resonance (MR) probe dubbed DOTA(Gd)-ANADYWR for MR imaging of HCC in mice. Materials and Methods: The longitudinal (R 1) relaxivity of DOTA(Gd)-ANADYWR was measured on a 3.0 T MR system . The specific tumor enhancement of the agent was investigated in four distinct mouse models, including subcutaneous, orthotopic, genetically engineered and chemically induced HCC mice. Results: The R 1 relaxivity value of DOTA(Gd)-ANADYWR is 5.11 mM− 1s− 1 at 3.0 T, which is similar to that of the nonspecific clinical agent Gadoteridol. DOTA(Gd)-ANADYWR generated superior enhanced MR signal in HCC lesions and provided complementary enhancement MR signals to the clinically available hepatobiliary MR contrast agent gadoxetate disodium (Gd-EOB-DTPA). Importantly, DOTA(Gd)-ANADYWR could efficiently visualize small HCC lesion (approximately 1 mm) which was hardly detected by the clinical Gd-EOB-DTPA. Conclusion: These findings suggest the potential application of this integrin α 6-targeted MR probe for the detection of HCC, particularly for small HCC.Keywords
This publication has 66 references indexed in Scilit:
- Integrin Targeted Delivery of ChemotherapeuticsTheranostics, 2011
- Integrin signalling adaptors: not only figurants in the cancer storyNature Reviews Cancer, 2010
- Integrin Alpha 6 Regulates Glioblastoma Stem CellsCell Stem Cell, 2010
- The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosisGut, 2009
- The integrinsGenome Biology, 2007
- Specific Targeting of Tumor Angiogenesis by RGD-Conjugated Ultrasmall Superparamagnetic Iron Oxide Particles Using a Clinical 1.5-T Magnetic Resonance ScannerCancer Research, 2007
- Integrin β4 signaling promotes tumor angiogenesisCancer Cell, 2004
- IntegrinsCell, 2002
- Differential expression of laminin receptors in human hepatocellular carcinomaGut, 1998
- Differential display and integrin alpha 6 messenger RNA overexpression in hepatocellular carcinomaHepatology, 1995